Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-21

Clinical Trial Update: Safety and Tolerability of VGB-R04 in Patients With Haemophilia B [EARLY_Phase 1]

View source ↗

Summary

An early-phase, safety and tolerability study of VGB-R04 in Hemophilia B is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VGB-R04

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Hemophilia B | EARLY_Phase 1 | Status: RECRUITING